瑞格列奈

CAS号
108157-52-4 ;135062-02-1
CCD编号
CCD00179640
分子式
C27 H36 N2 O4
分子量
452.591

基本信息

产品名称: 瑞格列奈
CAS: 108157-52-4 ;135062-02-1
中文同义词: 瑞格列奈
英文同义词: (S)-2-ETHOXY-4-[2-[[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]BENZOIC ACID ; S-(+)-2-ETHOXY-4-[2-(3-METHYL-1-[2-(PIPERIDIN-1-YL)PHENYL]BUTYLAMINO)-2-OXOETHYL]BENZOIC ACID ; AG-EE-623 ; REPAGLINIDE ; 2-ETHOXY-4-[2-[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID ; PRANDIN ; 2-ETHOXY-4-[2-[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]-BENZOIC ACID ; 2-ETHOXY-4-([(S)-3-METHYL-1-(2-PIPERIDIN-1-YL-PHENYL)-BUTYLCARBAMOYL]-METHYL)-BENZOIC ACID ; (S)-(+)-2-ETHOXY-4-[N-[1-(2-PIPERIDINOPHENYL)-3-METHYL-1-BUTYL]AMINOCARBONYLMETHYL]BENZOIC ACID ; BENZOIC ACID, 2-ETHOXY-4-[2-[[(1S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]BUTYL]AMINO]-2-OXOETHYL]- ; NOVONORM ; RAPAGLINIDE ; AG-EE 623ZW ; (S)-2-ETHOXY-4-(2-(3-METHYL-1-(2-(PIPERIDIN-1-YL)PHENYL)BUTYLAMINO)-2-OXOETHYL)BENZOIC ACID ; GLUCONORM
MDL号: MFCD00906179
氢键受体数量: 6
氢键供体数量: 2
Smile: CCOc1cc(ccc1C(=O)O)CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3
InChi: InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1
InChiKey: InChIKey=FAEKWTJYAYMJKF-QHCPKHFHSA-N

性质

注解: OTHER NOTES: SALES RESTRICTIONS MAY APPLY
BIOCHEM/PHYSIOL ACTIONS: REPAGLINIDE IS A POTENT SHORT-ACTING INSULIN SECRETAGOGUE THAT ACTS BY CLOSING ATP-SENSITIVE POTASSIUM (KATP) CHANNELS IN THE PLASMA MEMBRANE OF THE PANCREATIC BETA CELL. IT REPRESENTS A NEW CLASS OF INSULIN SECRETAGOGUES, STRUCTURALLY UNRELATED TO SULPHONYLUREAS, WHICH WERE DEVELOPED FOR THE TREATMENT OF TYPE 2 DIABETES
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA

安全信息

WGK德国: 2

* If the product has intellectual property rights, a license granted is must or contact us.